Development and characterization of a cell based assay for the validation of mutant IDH1 inhibitors

被引：0
|
作者：
Fer, Nicole D. [1 ]
Harris, Erik [1 ]
Fox, Stephen [1 ]
Zhou, Ming [1 ]
Simpson, Catherine [2 ]
Liu, Jing [2 ]
Korboukh, Ilia [2 ]
Hull-Ryde, Emily A. [2 ]
Janzen, William P. [2 ]
Frye, Stephen V. [2 ]
Monks, Anne [1 ]
Teicher, Beverly [3 ]
Rapisarda, Annamaria [1 ]
机构：
[1] Leidos Biomed Res Inc, Frederick, MD USA
[2] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC USA
[3] NCI, Mol Pharmacol Lab, Div Canc Treatment & Diag, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-3741
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3741
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Inhibitors of mutant IDH1 and IDH2
    Pamela Feliciano
    Nature Genetics, 2013, 45 (5) : 477 - 477
  • [2] Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform Selectivity
    Xie, Xiaoling
    Baird, Daniel
    Bowen, Kimberly
    Capka, Vladimir
    Chen, Jinyun
    Chenail, Gregg
    Cho, YoungShin
    Dooley, Julia
    Farsidjani, Ali
    Fortin, Pascal
    Kohls, Darcy
    Kulathila, Raviraj
    Lin, Fallon
    McKay, Daniel
    Rodrigues, Lindsey
    Sage, David
    Toure, B. Barry
    van der Plas, Simon
    Wright, Kirk
    Xu, Ming
    Yin, Hong
    Levell, Julian
    Pagliarini, Raymond A.
    STRUCTURE, 2017, 25 (03) : 506 - 513
  • [3] CHARACTERIZATION OF MUTANT IDH1 OLIGODENDROGLIOMAS
    Heinz, Rick
    Holmen, Sheri
    NEURO-ONCOLOGY, 2019, 21 : 263 - 263
  • [4] Novel IDH1 mutant inhibitors identified
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2015, 14 (12) : 820 - 820
  • [5] Mutant IDH1 is required for IDH1 mutated tumor cell growth
    Jin, Genglin
    Pirozzi, Christopher J.
    Chen, Lee H.
    Lopez, Giselle Y.
    Duncan, Christopher G.
    Feng, Jie
    Spasojevic, Ivan
    Bigner, Darell D.
    He, Yiping
    Yan, Hai
    ONCOTARGET, 2012, 3 (08) : 774 - 782
  • [6] PARP Inhibitors Are Effective in IDH1/2 Mutant MDS and AML Resistant to Targeted IDH Inhibitors
    Gbyli, Rana
    Song, Yuanbin
    Liu, Wei
    Gao, Yimeng
    Chandhok, Namrata S.
    Fu, Xiaoying
    Wang, Xiaman
    Patel, Amisha
    Sundaram, Ranjini
    Tebaldi, Toma
    Biancon, Giulia
    Ardasheva, Anastasia
    Qin, Ashley
    Sadykov, Mukhtar
    Mamillapalli, Padmavathi
    Flavell, Richard
    Prebet, Thomas
    Bindra, Ranjit
    Halene, Stephanie
    BLOOD, 2019, 134
  • [7] Process Development of a Tricyclic Diazepine-Based IDH1 Mutant Inhibitor
    Maddess, Matthew L.
    Cleator, Ed
    Morimoto, Mariko
    Goodyear, Adrian
    Dieguez-Vazquez, Alejandro
    Gibb, Andrew
    Kirtley, Andy
    Christensen, Melodie
    Song, Chaohui
    Peng, Feng
    Alam, Mahbub
    Keen, Stephen P.
    Oliver, Steven F.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2024, 28 (06) : 2343 - 2354
  • [8] New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
    Okoye-Okafor, Ujunwa C.
    Bartholdy, Boris
    Cartier, Jessy
    Gao, Enoch N.
    Pietrak, Beth
    Rendina, Alan R.
    Rominger, Cynthia
    Quinn, Chad
    Smallwood, Angela
    Wiggall, Kenneth J.
    Reif, Alexander J.
    Schmidt, Stanley J.
    Qi, Hongwei
    Zhao, Huizhen
    Joberty, Gerard
    Faelth-Savitski, Maria
    Bantscheff, Marcus
    Drewes, Gerard
    Duraiswami, Chaya
    Brady, Pat
    Groy, Arthur
    Narayanagari, Swathi-Rao
    Antony-Debre, Ileana
    Mitchell, Kelly
    Wang, Heng Rui
    Kao, Yun-Ruei
    Christopeit, Maximilian
    Carvajal, Luis
    Barreyro, Laura
    Paietta, Elisabeth
    Makishima, Hideki
    Will, Britta
    Concha, Nestor
    Adams, Nicholas D.
    Schwartz, Benjamin
    McCabe, Michael T.
    Maciejewski, Jaroslav
    Verma, Amit
    Steidl, Ulrich
    NATURE CHEMICAL BIOLOGY, 2015, 11 (11) : 878 - U107
  • [9] Clinical development of IDH1 inhibitors for cancer therapy
    Zarei, Mehrdad
    Hue, Jonathan J.
    Hajihassani, Omid
    Graor, Hallie J.
    Katayama, Erryk S.
    Loftus, Alexander W.
    Bajor, David
    Rothermel, Luke D.
    Vaziri-Gohar, Ali
    Winter, Jordan M.
    CANCER TREATMENT REVIEWS, 2022, 103
  • [10] New Allosteric Inhibitors of Mutant IDH1 in Acute Myeloid Leukemia
    Okoye-Okafor, Ujunwa Cynthia
    Bartholdy, Boris
    Cartier, Jessy
    Gao, Enoch
    Pietrak, Beth
    Rendina, Alan R.
    Rominger, Cynthia
    Quinn, Chad
    Smallwood, Angela
    Wiggall, Ken
    Reif, Alexander
    Schmidt, Stan
    Qi, Hongwei
    Zhao, Huizhen
    Joberty, Gerard
    Faelth-Savitski, Maria
    Bantscheff, Marcus
    Drewes, Gerard
    Duraiswami, Chaya
    Brady, Pat
    Narayanagari, Swathi-rao
    Antony-Debre, Ileana
    Mitchell, Kelly
    Carvajal, Luis
    Wang, Heng Rui
    Barreyro, Laura
    Kao, Yun-Ruei
    Christopeit, Maximilian
    Paietta, Elisabeth
    Makishima, Hideki
    Will, Britta
    Concha, Nestor
    Adams, Nicholas
    Schwartz, Benjamin
    McCabe, Michael T.
    Maciejewski, Jaroslaw P.
    Verma, Amit
    Steidl, Ulrich
    BLOOD, 2015, 126 (23)
12345